Search - tctmd.com

Displaying 61 - 70 of 70

Sort: Relevancy | Date

News Industry News

Fondazione Ricerca e Innovazione Cardiovascolare Completes Enrollment in TRANSFORM II RCT, A landmark study comparing MagicTouch SCB vs DES in Native Coronary Vessels

June 12, 2025

News Conference News EuroPCR 2025

IVL Effective in Severely Calcified Lesions, Especially in Women

Yael L. Maxwell

May 22, 2025

Presentation Fellows 2025

Case and Technique Reviews: In-Stent Restenosis

Presenter: Rhian E. Davies

May 17, 2025

News Conference News CX Symposium 2025

Bioresorbable Scaffold for CLTI Appears to Be an Economical Option: LIFE-BTK

L.A. McKeown

April 24, 2025

News Conference News CRT 2025

AGENT IDE: DCB Performance for In-Stent Restenosis Lasts Out to 2 Years

L.A. McKeown

March 10, 2025

News Daily News

Philips Recalls Tack Endovascular Systems and Stops Distribution

L.A. McKeown

March 03, 2025

Presentation CTO 2025

Subintimal Plaque Modification and Neo-Lumen Creation for Management of Resistant In-Stent Restenosis

Presenter: Omar Abdelhai

February 28, 2025

Presentation CTO 2025

Hydrodynamic Contrast Recanalization of Chronically Occluded In-stent Restenosis

Presenter: Brian Li

February 28, 2025

News Daily News

PERFORMANCE II: Low Stroke Rate Seen With All-Inclusive Carotid Stent

L.A. McKeown

February 11, 2025

News Daily News

FDA Issues Early Alert About Risks of Peripheral Atherectomy Device

L.A. McKeown

February 07, 2025

Advertisement

Fondazione Ricerca e Innovazione Cardiovascolare Completes Enrollment in TRANSFORM II RCT, A landmark study comparing MagicTouch SCB vs DES in Native Coronary Vessels

IVL Effective in Severely Calcified Lesions, Especially in Women

Case and Technique Reviews: In-Stent Restenosis

Bioresorbable Scaffold for CLTI Appears to Be an Economical Option: LIFE-BTK

AGENT IDE: DCB Performance for In-Stent Restenosis Lasts Out to 2 Years

Philips Recalls Tack Endovascular Systems and Stops Distribution

Subintimal Plaque Modification and Neo-Lumen Creation for Management of Resistant In-Stent Restenosis

Hydrodynamic Contrast Recanalization of Chronically Occluded In-stent Restenosis

PERFORMANCE II: Low Stroke Rate Seen With All-Inclusive Carotid Stent

FDA Issues Early Alert About Risks of Peripheral Atherectomy Device

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content